BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

PLoS By Category | Recent PLoS Articles
Science Policy

Why Did Most French GPs Choose Not to Join the Voluntary National Pay-for-Performance Program?
Published: Monday, September 09, 2013
Author: Olivier Saint-Lary et al.

by Olivier Saint-Lary, Erik Bernard, Jonathan Sicsic, Isabelle Plu, Irène François-Purssell, Carine Franc

Background

In 2009, a voluntary pay for performance (P4P) scheme for primary care physicians was introduced in France through the ‘Contract for Improving Individual Practice’ (CAPI). Although the contract could be interrupted at any time and without any penalty, two-thirds of French general practitioners chose not to participate. We studied what factors motivated general practitioners not to subscribe to the P4P contract, and particularly their perception of the ethical risks that may be associated with adhering to a CAPI.

Method

A cross-sectional survey among French general practitioners using an online questionnaire based on focus group discussion results. Descriptive and multivariate statistical analyses with logistic regression.

Results

A sample of 1,016 respondents, representative of French GPs. The variables that were associated with the probability of not signing a CAPI were “discomfort that patients were not informed of the signing of a P4P contract by their doctors” (OR?=?8.24, 95% CI?=?4.61–14.71), “the risk of conflicts of interest” (OR?=?4.50, 95% CI?=?2.42–8.35), “perceptions by patients that doctors may risk breaching professional ethics” (OR?=?4. 35, 95% CI?=?2.43–7.80) and “the risk of excluding the poorest patients” (OR?=?2.66, 95% CI?=?1.53–4.63).

Conclusion

The perception of ethical risks associated with P4P may have hampered its success. Although the CAPI was extended to all GPs in 2012, our results question the relevance of the program itself by shedding light on potential adverse effects.

  More...

 

//-->